Вопросы современной педиатрии (Dec 2014)
THE NATIONAL CONSENSUS PROJECT* «CYSTIC FIBROSIS: DEFINITION, DIAGNOSTIC CRITERIA, AND THERAPY». SECTION «INHALATION THERAPY» (ABRIDGED)
- Ye. L. Amelina,
- I. K. Asherova,
- I. K. Volkov,
- Т. Ye. Gembitskaya,
- Ye. K. Ginter,
- N. А. Il’yenkova,
- N. I. Kapranov,
- I. P. Karimova,
- N. Yu. Kashirskaya,
- Ye. I. Kondrat’yeva,
- М. N. Kostyleva,
- S. А. Krasovsky,
- N. B. Merzlova,
- L. P. Nazarenko,
- L. S. Namazova-Baranova,
- А. F. Neretina,
- V. S. Nikonova,
- А. V. Orlov,
- S. S. Postnikov,
- Т. А. Protasova,
- S. Yu. Semykin,
- D. F. Sergienko,
- О. I. Simonova,
- I. D. Uspenskaya,
- М. Yu. Chernukha,
- L. А. Shabalova,
- I. А. Shaginyan,
- V. D. Sherman
Affiliations
- Ye. L. Amelina
- Pulmonology Research Institute, Moscow
- I. K. Asherova
- Children's Clinical Hospital No.1, Yaroslavl
- I. K. Volkov
- Sechenov First Moscow State Medical University
- Т. Ye. Gembitskaya
- Pulmonology Research Institute of Pavlov First Saint Petersburg State Medical University
- Ye. K. Ginter
- Research Centre of Medical Genetics, Moscow
- N. А. Il’yenkova
- V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
- N. I. Kapranov
- Research Centre of Medical Genetics, Moscow
- I. P. Karimova
- Chelyabinsk Regional Children's Clinical Hospital
- N. Yu. Kashirskaya
- Research Centre of Medical Genetics, Moscow
- Ye. I. Kondrat’yeva
- Research Centre of Medical Genetics, Moscow
- М. N. Kostyleva
- Russian Children's Clinical Hospital, Moscow
- S. А. Krasovsky
- Pulmonology Research Institute, Moscow
- N. B. Merzlova
- E.A. Vagner Perm State Academy of Medicine
- L. P. Nazarenko
- Research Institute for Medical Genetics, Tomsk
- L. S. Namazova-Baranova
- Scientific Centre of Children Health, Moscow
- А. F. Neretina
- N.N. Burdenko Voronezh State Medical Academy
- V. S. Nikonova
- Research Centre of Medical Genetics, Moscow
- А. V. Orlov
- St. Olga Municipal Children's Hospital, Saint Petersburg
- S. S. Postnikov
- Russian Children's Clinical Hospital, Moscow
- Т. А. Protasova
- Kemerovo Regional Clinical Hospital
- S. Yu. Semykin
- Research Centre of Medical Genetics, Moscow
- D. F. Sergienko
- Astrakhan State Medical Academy
- О. I. Simonova
- Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University
- I. D. Uspenskaya
- Nizhny Novgorod Scientific Research Institute of Paediatric Gastroenterology
- М. Yu. Chernukha
- N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Moscow
- L. А. Shabalova
- Research Centre of Medical Genetics, Moscow
- I. А. Shaginyan
- N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Moscow
- V. D. Sherman
- Research Centre of Medical Genetics, Moscow
- DOI
- https://doi.org/10.15690/vsp.v13i6.1209
- Journal volume & issue
-
Vol. 13,
no. 6
pp. 89 – 95
Abstract
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including glucocorticoids, recommended for use in cystic fibrosis patients of all age groups in the territory of the Russian Federation
Keywords
- cystic fibrosis
- inhalation therapy
- bronchodilators
- mucolytics
- dornase alfa
- hypertonic saline
- glucocorticoids
